• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔注射次氮基三乙酸铁(Fe-NTA)后大鼠肾脏DNA中8-羟基脱氧鸟苷(8-OH-dG)的形成。

Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA).

作者信息

Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y

机构信息

Division of Toxicology, National Institute of Hygienic Sciences, Tokyo, Japan.

出版信息

Carcinogenesis. 1990 Feb;11(2):345-7. doi: 10.1093/carcin/11.2.345.

DOI:10.1093/carcin/11.2.345
PMID:2302761
Abstract

A significant increase of 8-hydroxydeoxyguanosine (8-OH-dG) was observed in the kidney DNA of rats given a renal carcinogen, the ferric complex of nitrilotriacetate (Fe-NTA) by single i.p. injection. By contrast, non- or weakly carcinogenic compounds, aluminum-nitrilotriacetate complex (Al-NTA), non-complexed NTA (Na2NTA) and ferric chloride had no effect on 8-OH-dG production in the kidney DNA. These results suggest the involvement of active oxygen radicals in Fe-NTA carcinogenesis.

摘要

通过单次腹腔注射给予大鼠肾致癌物次氮基三乙酸铁络合物(Fe-NTA)后,在大鼠肾脏DNA中观察到8-羟基脱氧鸟苷(8-OH-dG)显著增加。相比之下,非致癌或弱致癌化合物,次氮基三乙酸铝络合物(Al-NTA)、未络合的NTA(Na2NTA)和氯化铁对肾脏DNA中8-OH-dG的产生没有影响。这些结果表明活性氧自由基参与了Fe-NTA致癌作用。

相似文献

1
Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA).腹腔注射次氮基三乙酸铁(Fe-NTA)后大鼠肾脏DNA中8-羟基脱氧鸟苷(8-OH-dG)的形成。
Carcinogenesis. 1990 Feb;11(2):345-7. doi: 10.1093/carcin/11.2.345.
2
Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in the rat kidney.褪黑素对大鼠肾脏中亚硝基三乙酸铁诱导的脂质过氧化和氧化性DNA损伤的抑制作用。
Toxicology. 1999 Nov 29;139(1-2):81-91. doi: 10.1016/s0300-483x(99)00100-6.
3
Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.用2-巯基乙烷磺酸盐和N-乙酰半胱氨酸预防次氮基三乙酸铁处理的大鼠的肾脏氧化损伤。
Jpn J Cancer Res. 1996 Sep;87(9):882-6. doi: 10.1111/j.1349-7006.1996.tb02115.x.
4
Increase in the 8-hydroxyguanine repair activity in the rat kidney after the administration of a renal carcinogen, ferric nitrilotriacetate.给予肾致癌物次氮基三乙酸铁后大鼠肾脏中8-羟基鸟嘌呤修复活性的增加。
Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):651-3. doi: 10.1289/ehp.96104s3651.
5
Comparative mutagenicities of bleomycin and ferric-nitrilotriacetate in lacZ mice.博来霉素和次氮基三乙酸铁对lacZ小鼠的比较致突变性
Cancer Lett. 2002 Dec 10;187(1-2):41-6. doi: 10.1016/s0304-3835(02)00382-8.
6
Increased 8-hydroxyguanine levels in DNA and its repair activity in rat kidney after administration of a renal carcinogen, ferric nitrilotriacetate.给予肾致癌物次氮基三乙酸铁后大鼠肾脏DNA中8-羟基鸟嘌呤水平及其修复活性的增加
Carcinogenesis. 1996 Nov;17(11):2419-22. doi: 10.1093/carcin/17.11.2419.
7
Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in the rat kidney after ferric nitrilotriacetate administration.
Cancer Lett. 1990 Oct 8;54(1-2):95-100. doi: 10.1016/0304-3835(90)90097-h.
8
The effects of exogenous glutathione and cysteine on oxidative stress induced by ferric nitrilotriacetate.
Cancer Lett. 1991 Jun 14;58(1-2):49-56. doi: 10.1016/0304-3835(91)90022-a.
9
Mutagenic effects of ferric nitrilotriacetate (Fe-NTA) on V79 Chinese hamster cells and its inhibitory effects on cell-cell communication.次氮基三乙酸铁(Fe-NTA)对V79中国仓鼠细胞的诱变作用及其对细胞间通讯的抑制作用。
Carcinogenesis. 1990 Feb;11(2):257-60. doi: 10.1093/carcin/11.2.257.
10
Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate.膳食姜黄素对用肾致癌物次氮基三乙酸铁处理的小鼠肾鸟氨酸脱羧酶活性升高的抑制作用。
Biochim Biophys Acta. 2005 Jun 10;1740(3):357-66. doi: 10.1016/j.bbadis.2004.09.006. Epub 2004 Sep 25.

引用本文的文献

1
The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies.饮食在肾细胞癌发病中的作用:观察性研究荟萃分析的伞状评价。
BMC Med. 2022 Feb 3;20(1):39. doi: 10.1186/s12916-021-02229-5.
2
Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms.维生素 B6 与糖尿病:关系与分子机制。
Int J Mol Sci. 2020 May 23;21(10):3669. doi: 10.3390/ijms21103669.
3
Dietary phytate lowers - mutational frequency, decreases DNA-adduct and hydroxyl radical formation in azoxymethane-induced colon cancer.
膳食植酸盐可降低偶氮甲烷诱导的结肠癌中的突变频率,减少DNA加合物和羟基自由基的形成。
Iran J Basic Med Sci. 2020 Jan;23(1):20-29. doi: 10.22038/IJBMS.2019.34374.8161.
4
Vitamin C intake and risk of renal cell carcinoma: a meta-analysis.维生素C摄入量与肾细胞癌风险:一项荟萃分析。
Sci Rep. 2015 Dec 8;5:17921. doi: 10.1038/srep17921.
5
Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes.Akt/mTOR的过度激活和结节性硬化蛋白的缺乏增加了糖尿病肾癌患者的氧化性DNA损伤。
Oncotarget. 2014 May 15;5(9):2542-50. doi: 10.18632/oncotarget.1833.
6
Nrf2 protects against As(III)-induced damage in mouse liver and bladder.Nrf2可保护小鼠肝脏和膀胱免受三价砷诱导的损伤。
Toxicol Appl Pharmacol. 2009 Oct 1;240(1):8-14. doi: 10.1016/j.taap.2009.06.010. Epub 2009 Jun 16.
7
Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention.姜黄素可减轻用肾致癌物次氮基三乙酸铁(Fe-NTA)处理的动物的氧化损伤:对癌症预防的意义。
Mol Cell Biochem. 2009 Apr;324(1-2):157-64. doi: 10.1007/s11010-008-9994-z. Epub 2009 Jan 23.
8
Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2'-deoxyguanosine-DNA glycosylase.糖尿病中氧化DNA损伤的机制:结节性硬化蛋白失活与DNA修复酶8-氧代-7,8-二氢-2'-脱氧鸟苷-DNA糖基化酶的下调
Diabetes. 2008 Oct;57(10):2626-36. doi: 10.2337/db07-1579. Epub 2008 Jul 3.
9
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.铝、氧化铝和氢氧化铝的人体健康风险评估。
J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. doi: 10.1080/10937400701597766.
10
Iron toxicity and chelation therapy.铁中毒与螯合疗法。
Int J Hematol. 2002 Oct;76(3):219-28. doi: 10.1007/BF02982791.